Antiviral drug discovery for emerging diseases and bioterrorism threats.
作者： Paul F Torrence , None
DOI:
关键词:
摘要: Preface. Contributors. 1. Introduction: Pestilence, Plague, Bioterrorism (Paul F. Torrence). 2. Viral and Antiviral Countermeasures (Mike Bray). 3. Overview of Drug Discovery Development (Christopher K. Tseng). 4. Targets Strategies for Emerging Diseases Threats (Erik De Clercq). 5. Perspectives the Therapy Against Arenavirus Infections (Elsa B. Damonte Cybele C. Garcia). 6. S-Adenosylhomocysteine Hydrolase Inhibitors as a Source Anti-Filovirus Agents (Stewart W. Schneller Minmin Yang). 7. Ebola Virus (Jillian M. Licata Ronald N. Harty). 8. IMPDH Inhibitors: (Vasu Nair). 9. Lethal Mutagenesis: Exploiting Error-Prone Replication Riboviruses (Jason D. Graci Craig E. Cameron). 10. Structural Biology Flaviviral Opportunities Design (Krishna Murthy). 11. Confronting New Old Threats: Broad Spectrum Potential Prenylation (Menashe Elazar Jeffrey S. Glenn). 12. West Nile Virus: Antivirals (Matthias Kalitzky, Holger Rohde, Peter Borowski). 13. The Emergence Pandemic Influenza A: Bioterrorist Versus Mother Nature (John Oxford, Alison Boyers, Alex Mann, R. Lambkin). 14. Smallpox (Earl Kern). 15. to Host Interferon Response: Role Vaccinia E3L K3L Genes (Jeffrey O. Langland, Vanessa Lancaster, Bertram L. Jacobs). 16. Broad-Spectrum Prophylaxis: Inhibition Infection by Polymer Grafting with Methoxypoly(ethylene glycol) (Lori McCoy Mark Scott). 17. Evasion System: Novel Torrence Linda Powell). Index.
cabdirect.org 参考文章(29)
D. R. Franz, Clinical recognition and management of patients exposed to biological warfare agents JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 399- 411 ,(1997) , 10.1001/JAMA.278.5.399
Robert O Baker, Mike Bray, John W Huggins, Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections. Antiviral Research. ,vol. 57, pp. 13- 23 ,(2003) , 10.1016/S0166-3542(02)00196-1
Stephanie L Ciesla, Julissa Trahan, W.Brad Wan, James R Beadle, Kathy A Aldern, George R Painter, Karl Y Hostetler, Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney Antiviral Research. ,vol. 59, pp. 163- 171 ,(2003) , 10.1016/S0166-3542(03)00110-4
G. Andrei, E. De Clercq, Molecular approaches for the treatment of hemorrhagic fever virus infections Antiviral Research. ,vol. 22, pp. 45- 75 ,(1993) , 10.1016/0166-3542(93)90085-W
A Monto, The role of antivirals in the control of influenza. Vaccine. ,vol. 21, pp. 1796- 1800 ,(2003) , 10.1016/S0264-410X(03)00075-6
Mike Bray, Jason Paragas, Experimental therapy of filovirus infections. Antiviral Research. ,vol. 54, pp. 1- 17 ,(2002) , 10.1016/S0166-3542(02)00005-0
Christopher F Basler, Andrea Mikulasova, Luis Martinez-Sobrido, Jason Paragas, Elke Mühlberger, Mike Bray, Hans-Dieter Klenk, Peter Palese, Adolfo García-Sastre, None, The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 Journal of Virology. ,vol. 77, pp. 7945- 7956 ,(2003) , 10.1128/JVI.77.14.7945-7956.2003
S. BAIZE, E. M. LEROY, A. J. GEORGES, M.-C. GEORGES-COURBOT, M. CAPRON, I. BEDJABAGA, J. LANSOUD-SOUKATE, E. MAVOUNGOU, Inflammatory responses in Ebola virus-infected patients Clinical and Experimental Immunology. ,vol. 128, pp. 163- 168 ,(2002) , 10.1046/J.1365-2249.2002.01800.X
Lisa D Rotz, Ali S Khan, Scott R Lillibridge, Stephen M Ostroff, James M Hughes, Public health assessment of potential biological terrorism agents. Emerging Infectious Diseases. ,vol. 8, pp. 225- 230 ,(2002) , 10.3201/EID0802.010164
RGJ Westendorp, JAM Langermans, TWJ Huizinga, CL Verweij, A Sturk, Genetic influence on cytokine production in meningococcal disease The Lancet. ,vol. 349, pp. 1912- 1913 ,(1997) , 10.1016/S0140-6736(05)63910-4